Skip to main content
Erschienen in: Pathology & Oncology Research 2/2020

04.04.2019 | Original Article

MicroRNA-182-5p Modulates Oral Squamous Cell Carcinoma Migration and Invasion Via Targeting MTSS1 Gene

verfasst von: Yan Guo, Xue Qiao, Li Zhu, Rongbo Song

Erschienen in: Pathology & Oncology Research | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Oral squamous cell carcinoma (OSCC) characterized with invasive growth, local metastasis and later stage diagnosis was a common malignancy in head and neck region. The aim of this study was to explore the relationship between miR-182-5p and OSCC, which will contribute to find potential biomarker for OSCC metastasis. MiR-182-5p expression level was detected by the quantitative real-time PCR (qRT-PCR). Cell migration and invasion ability were examined by scratch and transwell assay. Loss-of function together with luciferase reporter assay were used to verify the miR-182-5p modulated OSCC cells migration and metastasis was mediated by MTSS1. The expression of MTSS1 protein was examined by western blotting. MiR-182-5p up-regulated in OSCC, was involved in the migration and invasion of OSCC and the increased miR-182-5p expression was correlated with lower OSCC differentiation grade, higher T and N stage. Bioinformatics analysis predicted MTSS1 gene was a potential target of miR-182-5p. Following co-transfection, qRT-PCR, luciferase activities assay and western blotting confirmed that MTSS1 gene was a direct target of miR-182-5p and silence of MTSS1 could reverse the effects of miR-182-5p on OSCC migration and invasion. MiR-182-5p was up-regulated in OSCC and the ability of miR-182-5p to promote MTSS1 repression may precipitate in the OSCC through bypassing cell migration and invasion control.
Literatur
1.
Zurück zum Zitat Krishna Rao SV, Mejia G, Roberts-Thomson K, Logan R (2013) Epidemiology of oral cancer in Asia in the past decade--an update (2000-2012). Asian Pac J Cancer Prev 14:5567–5577CrossRef Krishna Rao SV, Mejia G, Roberts-Thomson K, Logan R (2013) Epidemiology of oral cancer in Asia in the past decade--an update (2000-2012). Asian Pac J Cancer Prev 14:5567–5577CrossRef
2.
Zurück zum Zitat de Morais EF, Mafra RP, Gonzaga AK,de Souza DL, Pinto LP, da Silveira ÉJ (2016) Prognostic Factors of Oral Squamous Cell Carcinoma in Young Patients: A Systematic Review. J Oral Maxillofac Surg, pii: S0278–2391(16): 31286–31281 de Morais EF, Mafra RP, Gonzaga AK,de Souza DL, Pinto LP, da Silveira ÉJ (2016) Prognostic Factors of Oral Squamous Cell Carcinoma in Young Patients: A Systematic Review. J Oral Maxillofac Surg, pii: S0278–2391(16): 31286–31281
3.
Zurück zum Zitat Kessler P, Grabenbauer G, Leher A, Bloch-Birkholz A, Vairaktaris E, Neukam FW (2008) Neoadjuvant and adjuvant therapy in patients with oral squamous cell carcinoma Long-term survival in a prospective, non-randomized study. Br J Oral Maxillofac Surg 46(1):1–5CrossRef Kessler P, Grabenbauer G, Leher A, Bloch-Birkholz A, Vairaktaris E, Neukam FW (2008) Neoadjuvant and adjuvant therapy in patients with oral squamous cell carcinoma Long-term survival in a prospective, non-randomized study. Br J Oral Maxillofac Surg 46(1):1–5CrossRef
4.
Zurück zum Zitat Leemans CR, Braakhuis BJ, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11:9–22CrossRef Leemans CR, Braakhuis BJ, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11:9–22CrossRef
5.
Zurück zum Zitat Huang S, Tan X, Huang Z, Chen Z, Lin P, Fu SW (2018) microRNA biomarkers in colorectal cancer liver metastasis. J Cancer 9(21):3867–3873CrossRef Huang S, Tan X, Huang Z, Chen Z, Lin P, Fu SW (2018) microRNA biomarkers in colorectal cancer liver metastasis. J Cancer 9(21):3867–3873CrossRef
6.
Zurück zum Zitat Shen J, Zhou W, Bi N, Song YM, Zhang FQ, Zhan QM, Wang LH (2018) MicroRNA-886-3P functions as a tumor suppressor in small cell lung cancer. Cancer Biol Ther 19(12):1185–1192CrossRef Shen J, Zhou W, Bi N, Song YM, Zhang FQ, Zhan QM, Wang LH (2018) MicroRNA-886-3P functions as a tumor suppressor in small cell lung cancer. Cancer Biol Ther 19(12):1185–1192CrossRef
7.
Zurück zum Zitat Shang C, Guo Y, Hong Y, Xue YX (2016) Long non-coding RNA TUSC7, a target of miR-23b, plays tumor-suppressing roles in human gliomas. Front Cell Neurosci 10:235CrossRef Shang C, Guo Y, Hong Y, Xue YX (2016) Long non-coding RNA TUSC7, a target of miR-23b, plays tumor-suppressing roles in human gliomas. Front Cell Neurosci 10:235CrossRef
8.
Zurück zum Zitat Kong P, Chen L, Yu M, Tao J, Liu J, Wang Y, Pan H, Zhou W, Wang S (2018) miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer. Cell Death Dis 9(11):1059CrossRef Kong P, Chen L, Yu M, Tao J, Liu J, Wang Y, Pan H, Zhou W, Wang S (2018) miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer. Cell Death Dis 9(11):1059CrossRef
9.
Zurück zum Zitat Zhao D, Zhang Y, Song L (2018) MiR-16-1 targeted silences far upstream element binding protein 1 to advance the Chemosensitivity to Adriamycin in gastric Cancer. Pathol Oncol Res 24(3):483–488CrossRef Zhao D, Zhang Y, Song L (2018) MiR-16-1 targeted silences far upstream element binding protein 1 to advance the Chemosensitivity to Adriamycin in gastric Cancer. Pathol Oncol Res 24(3):483–488CrossRef
10.
Zurück zum Zitat Shang C, Tang W, Pan C, Hu XH, Hong Y (2018) Long non-coding RNA TUSC7 inhibits temozolomide resistance by targeting miR-10a in glioblastoma. Cancer Chemother Pharmacol 81(4):671–678CrossRef Shang C, Tang W, Pan C, Hu XH, Hong Y (2018) Long non-coding RNA TUSC7 inhibits temozolomide resistance by targeting miR-10a in glioblastoma. Cancer Chemother Pharmacol 81(4):671–678CrossRef
11.
Zurück zum Zitat Sharifi M, Moridnia A (2017) Apoptosis-inducing and antiproliferative effect by inhibition of miR-182-5p through the regulation of CASP9 expression in human breast cancer. Cancer Gene Ther 24(2):75–82CrossRef Sharifi M, Moridnia A (2017) Apoptosis-inducing and antiproliferative effect by inhibition of miR-182-5p through the regulation of CASP9 expression in human breast cancer. Cancer Gene Ther 24(2):75–82CrossRef
12.
Zurück zum Zitat Li Y, Chen S, Shan Z, Bi L, Yu S, Li Y, Xu S (2017) miR-182-5p improves the viability, mitosis, migration, and invasion ability of human gastric cancer cells by down-regulating RAB27A. Biosci Rep 37(3):pii: BSR20170136CrossRef Li Y, Chen S, Shan Z, Bi L, Yu S, Li Y, Xu S (2017) miR-182-5p improves the viability, mitosis, migration, and invasion ability of human gastric cancer cells by down-regulating RAB27A. Biosci Rep 37(3):pii: BSR20170136CrossRef
13.
Zurück zum Zitat Hirata H, Ueno K, Shahryari V, Deng G, Tanaka Y, Tabatabai ZL, Hinoda Y, Dahiya R (2013) MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer. PLoS One 8(1):e55502CrossRef Hirata H, Ueno K, Shahryari V, Deng G, Tanaka Y, Tabatabai ZL, Hinoda Y, Dahiya R (2013) MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer. PLoS One 8(1):e55502CrossRef
14.
Zurück zum Zitat Suzuki R, Amatya VJ, Kushitani K, Kai Y, Kambara T, Takeshima Y (2018) miR-182 and miR-183 promote cell proliferation and invasion by targeting FOXO1 in mesothelioma. Front Oncol 8:446CrossRef Suzuki R, Amatya VJ, Kushitani K, Kai Y, Kambara T, Takeshima Y (2018) miR-182 and miR-183 promote cell proliferation and invasion by targeting FOXO1 in mesothelioma. Front Oncol 8:446CrossRef
15.
Zurück zum Zitat Golbakhsh MR, Boddouhi B, Hatami N, Goudarzi PK, Shakeri M, Yahaghi E, Taheriazam A (2017) Down-regulation of microRNA-182 and microRNA-183 predicts progression of osteosarcoma. Arch Med Sci 13(6):1352–1356CrossRef Golbakhsh MR, Boddouhi B, Hatami N, Goudarzi PK, Shakeri M, Yahaghi E, Taheriazam A (2017) Down-regulation of microRNA-182 and microRNA-183 predicts progression of osteosarcoma. Arch Med Sci 13(6):1352–1356CrossRef
16.
Zurück zum Zitat Xu X, Wu J, Li S, Hu Z, Xu X, Zhu Y, Liang Z, Wang X, Lin Y, Mao Y, Chen H, Luo J, Liu B, Zheng X, Xie L (2014) Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway. Mol Cancer 13:109CrossRef Xu X, Wu J, Li S, Hu Z, Xu X, Zhu Y, Liang Z, Wang X, Lin Y, Mao Y, Chen H, Luo J, Liu B, Zheng X, Xie L (2014) Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway. Mol Cancer 13:109CrossRef
17.
Zurück zum Zitat Guo Y, Ren MS, Shang C, Zhu L, Zhong M (2015) MTSS1 gene regulated by miR-96 inhibits cell proliferation and metastasis in tongue squamous cellular carcinoma Tca8113 cell line. Int J Clin Exp Med 8(9):15441–15449PubMedPubMedCentral Guo Y, Ren MS, Shang C, Zhu L, Zhong M (2015) MTSS1 gene regulated by miR-96 inhibits cell proliferation and metastasis in tongue squamous cellular carcinoma Tca8113 cell line. Int J Clin Exp Med 8(9):15441–15449PubMedPubMedCentral
18.
Zurück zum Zitat Marshall J (2011) Transwell(®) invasion assays. Methods Mol Biol 769:97–110CrossRef Marshall J (2011) Transwell(®) invasion assays. Methods Mol Biol 769:97–110CrossRef
19.
Zurück zum Zitat Wang J, Li J, Shen J, Wang C, Yang L, Zhang X (2012) MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma. BMC Cancer 12:227CrossRef Wang J, Li J, Shen J, Wang C, Yang L, Zhang X (2012) MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma. BMC Cancer 12:227CrossRef
20.
Zurück zum Zitat Lv Q, Hu JX, Li YJ, Xie N, Song DD, Zhao W, Yan YF, Li BS, Wang PY, Xie SY (2017) MiR-320a effectively suppresses lung adenocarcinoma cell proliferation and metastasis by regulating STAT3 signals. Cancer Biol Ther 18(3):142–151CrossRef Lv Q, Hu JX, Li YJ, Xie N, Song DD, Zhao W, Yan YF, Li BS, Wang PY, Xie SY (2017) MiR-320a effectively suppresses lung adenocarcinoma cell proliferation and metastasis by regulating STAT3 signals. Cancer Biol Ther 18(3):142–151CrossRef
21.
Zurück zum Zitat Rajabpour A, Afgar A, Mahmoodzadeh H, Radfar JE, Rajaei F, Teimoori-Toolabi L (2017) MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic cancer cells. Cancer Chemother Pharmacol 80(4):765–775CrossRef Rajabpour A, Afgar A, Mahmoodzadeh H, Radfar JE, Rajaei F, Teimoori-Toolabi L (2017) MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic cancer cells. Cancer Chemother Pharmacol 80(4):765–775CrossRef
22.
Zurück zum Zitat Wang J, Chen T, Shan G (2017) miR-148b regulates proliferation and differentiation of neural stem cells via Wnt/β-catenin signaling in rat ischemic stroke model. Front Cell Neurosci 11:329CrossRef Wang J, Chen T, Shan G (2017) miR-148b regulates proliferation and differentiation of neural stem cells via Wnt/β-catenin signaling in rat ischemic stroke model. Front Cell Neurosci 11:329CrossRef
23.
Zurück zum Zitat Xi Z, Wang P, Xue Y, Shang C, Liu X, Ma J, Li Z, Li Z, Bao M, Liu Y (2017) Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating quaking gene isoform 6. Oncotarget. 8(15):24949–24963CrossRef Xi Z, Wang P, Xue Y, Shang C, Liu X, Ma J, Li Z, Li Z, Bao M, Liu Y (2017) Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating quaking gene isoform 6. Oncotarget. 8(15):24949–24963CrossRef
24.
Zurück zum Zitat Tsuchiyama K, Ito H, Taga M, Naganuma S, Oshinoya Y, Nagano K, Yokoyama O, Itoh H (2013) Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer. Prostate. 73(8):827–834CrossRef Tsuchiyama K, Ito H, Taga M, Naganuma S, Oshinoya Y, Nagano K, Yokoyama O, Itoh H (2013) Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer. Prostate. 73(8):827–834CrossRef
25.
Zurück zum Zitat Xue J, Zhou A, Wu Y, Morris SA, Lin K, Amin S, Verhaak R, Fuller G, Xie K, Heimberger AB, Huang S (2016) miR-182-5p induced by STAT3 activation promotes glioma tumorigenesis. Cancer Res 76(14):4293–4304CrossRef Xue J, Zhou A, Wu Y, Morris SA, Lin K, Amin S, Verhaak R, Fuller G, Xie K, Heimberger AB, Huang S (2016) miR-182-5p induced by STAT3 activation promotes glioma tumorigenesis. Cancer Res 76(14):4293–4304CrossRef
26.
Zurück zum Zitat Zeleniak AE, Huang W, Brinkman MK, Fishel ML, Hill R (2017) Loss of MTSS1 results in increased metastatic potential in pancreatic cancer. Oncotarget. 8(10):16473–16487CrossRef Zeleniak AE, Huang W, Brinkman MK, Fishel ML, Hill R (2017) Loss of MTSS1 results in increased metastatic potential in pancreatic cancer. Oncotarget. 8(10):16473–16487CrossRef
27.
Zurück zum Zitat Ling DJ, Chen ZS, Liao QD, Feng JX, Zhang XY, Yin TY (2016) Differential effects of MTSS1 on invasion and proliferation in subtypes of non-small cell lung cancer cells. Exp Ther Med 12(2):1225–1231CrossRef Ling DJ, Chen ZS, Liao QD, Feng JX, Zhang XY, Yin TY (2016) Differential effects of MTSS1 on invasion and proliferation in subtypes of non-small cell lung cancer cells. Exp Ther Med 12(2):1225–1231CrossRef
28.
Zurück zum Zitat Shi W, Hasimu G, Wang Y, Li N, Chen M, Zhang H (2015) MTSS1 is an independent prognostic biomarker for survival in intrahepatic cholangiocarcinoma patients. Am J Transl Res 7(10):1974–1983PubMedPubMedCentral Shi W, Hasimu G, Wang Y, Li N, Chen M, Zhang H (2015) MTSS1 is an independent prognostic biomarker for survival in intrahepatic cholangiocarcinoma patients. Am J Transl Res 7(10):1974–1983PubMedPubMedCentral
Metadaten
Titel
MicroRNA-182-5p Modulates Oral Squamous Cell Carcinoma Migration and Invasion Via Targeting MTSS1 Gene
verfasst von
Yan Guo
Xue Qiao
Li Zhu
Rongbo Song
Publikationsdatum
04.04.2019
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 2/2020
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-019-00647-8

Weitere Artikel der Ausgabe 2/2020

Pathology & Oncology Research 2/2020 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.